In the Pharmaceuticals & Drugs sector, Dishman Carbogen Amcis Ltd. is underperforming relative to its peers, particularly in growth and profitability metrics. Companies like Sun Pharmaceutical Industries and Dr. Reddy's Laboratories exhibit strong financial health, while Dishman's high PE ratio coupled with low profitability metrics raises concerns about its valuation. Overall, there are solid value picks in the sector, alongside some financially stressed firms.

• • Dishman Carbogen Amcis has weak growth and profitability metrics compared to peers.
• • Sun Pharmaceutical and Dr. Reddy's Laboratories are sector leaders in profitability and growth.
• • Dishman has a high PE ratio and low PAT margin, raising valuation concerns.
• • Cipla Ltd. appears to be a strong value pick with solid growth and reasonable valuation metrics.